We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XIFR
201
XPLR Infrastructure LP
XIFR
$1.11B
$11.9M 0.11%
198,843
+18,687
+10% +$1.11M
TJX icon
202
TJX Companies
TJX
$178B
$11.8M 0.11%
212,953
-17,764
-8% -$957K
ARWR icon
203
Arrowhead Research
ARWR
$12.1B
$11.7M 0.11%
271,146
-50,000
-16% -$2.16M
BDX icon
204
Becton Dickinson
BDX
$45.8B
$11.6M 0.11%
51,260
-5
-0% -$1.23K
BZUN
205
Baozun
BZUN
$168M
$11.6M 0.11%
358,000
-160,000
-31% -$6.36M
MNTA
206
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11.5M 0.11%
219,575
-187,445
-46% -$7.76M
SHW icon
207
Sherwin-Williams
SHW
$87.4B
$11.5M 0.11%
49,524
-3,072
-6% -$671K
MDGL icon
208
Madrigal Pharmaceuticals
MDGL
$12.4B
$11.2M 0.11%
94,584
-8,000
-8% -$869K
TRV icon
209
Travelers Companies
TRV
$82.9B
$11.2M 0.11%
103,563
+74,151
+252% +$8.5M
ITCI
210
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11M 0.1%
430,000
-140,000
-25% -$3.19M
SRE icon
211
Sempra
SRE
$59.2B
$11M 0.1%
186,178
+115,618
+164% +$7.12M
PSNL icon
212
Personalis
PSNL
$1.27B
$11M 0.1%
507,605
-16,145
-3% -$321K
KMB icon
213
Kimberly-Clark
KMB
$37.5B
$11M 0.1%
74,250
-189,997
-72% -$28.5M
MRSN
214
DELISTED
Mersana Therapeutics
MRSN
$10.9M 0.1%
23,508
-322
-1% -$163K
FOLD
215
DELISTED
Amicus Therapeutics
FOLD
$10.9M 0.1%
771,588
+30,000
+4% +$437K
EL icon
216
Estee Lauder
EL
$30.7B
$10.8M 0.1%
49,343
-58,840
-54% -$12.1M
GWPH
217
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.6M 0.1%
108,427
-11,535
-10% -$1.33M
BILI icon
218
Bilibili
BILI
$7.56B
$10.5M 0.1%
253,100
+71,600
+39% +$3.16M
BLK icon
219
Blackrock
BLK
$170B
$10.4M 0.1%
18,519
+8,324
+82% +$4.75M
KYNB
220
Kyntra Bio
KYNB
$28.2M
$10.4M 0.1%
10,122
+1,566
+18% +$1.69M
GH icon
221
Guardant Health
GH
$19B
$10.3M 0.1%
92,338
+13,751
+17% +$1.26M
DE icon
222
Deere & Co
DE
$173B
$10.3M 0.1%
46,509
-153
-0.3% -$29.5K
ARGX icon
223
argenx
ARGX
$54.6B
$10.2M 0.1%
39,023
-20,884
-35% -$5.02M
TTEK icon
224
Tetra Tech
TTEK
$8.7B
$10.2M 0.1%
535,700
+42,640
+9% +$758K
AKAM icon
225
Akamai
AKAM
$16.3B
$10.2M 0.1%
92,434
+42,420
+85% +$4.71M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.